Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 322

1.
2.

Multidrug-resistance phenotype in Chinese hamster ovary cells.

Ling V, Kartner N, Sudo T, Siminovitch L, Riordan JR.

Cancer Treat Rep. 1983 Oct;67(10):869-74. Review.

PMID:
6354434
4.

Sequestration of doxorubicin in vesicles in a multidrug-resistant cell line (LZ-100).

Sognier MA, Zhang Y, Eberle RL, Sweet KM, Altenberg GA, Belli JA.

Biochem Pharmacol. 1994 Jul 19;48(2):391-401.

PMID:
7914406
5.
6.

Diversity of multidrug resistance in mammalian cells.

Devine SE, Melera PW.

J Biol Chem. 1994 Feb 25;269(8):6133-9.

8.

Reversal of multidrug resistance in Chinese hamster ovary cells by the immunosuppressive agent rapamycin.

Hoof T, Demmer A, Christians U, Tümmler B.

Eur J Pharmacol. 1993 Jun 15;246(1):53-8.

PMID:
7689059
9.

DNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression.

Debenham PG, Kartner N, Siminovitch L, Riordan JR, Ling V.

Mol Cell Biol. 1982 Aug;2(8):881-9.

10.
11.

Characterization of auromomycin-resistant hamster cell mutants that display a multidrug resistance phenotype.

Rauscher FJ 3rd, Beerman TA, Baker RM.

Mol Pharmacol. 1990 Aug;38(2):198-206.

PMID:
2143555
12.

Cells resistant to cytotoxic drugs are recognized by monoclonal antibody.

O'Hara CJ, Grover J, Price GB.

J Clin Immunol. 1984 Sep;4(5):403-11.

PMID:
6149230
14.

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.

Juliano RL, Ling V.

Biochim Biophys Acta. 1976 Nov 11;455(1):152-62.

PMID:
990323
15.

Drug resistance and membrane alteration in mutants of mammalian cells.

Ling V.

Can J Genet Cytol. 1975 Dec;17(4):503-15.

PMID:
1203765
16.

Reversal of the multidrug-resistant phenotype of Chinese hamster ovary cells by L-histidinol.

Warrington RC, Fang WD.

J Natl Cancer Inst. 1989 May 10;81(10):798-803.

PMID:
2716073
17.

Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines.

Riordan JR, Deuchars K, Kartner N, Alon N, Trent J, Ling V.

Nature. 1985 Aug 29-Sep 4;316(6031):817-9.

PMID:
2863759
18.

Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185----Val-185 substitution in P-glycoprotein.

Safa AR, Stern RK, Choi K, Agresti M, Tamai I, Mehta ND, Roninson IB.

Proc Natl Acad Sci U S A. 1990 Sep;87(18):7225-9.

19.

Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.

Liu ZL, Onda K, Tanaka S, Toma T, Hirano T, Oka K.

Cancer Chemother Pharmacol. 2002 May;49(5):391-7. Epub 2002 Feb 14.

PMID:
11976833
20.

Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.

Beketic-Oreskovic L, Durán GE, Chen G, Dumontet C, Sikic BI.

J Natl Cancer Inst. 1995 Nov 1;87(21):1593-602.

PMID:
7563202
Items per page

Supplemental Content

Write to the Help Desk